Clinical Trial Update: Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

View source ↗

Summary

A clinical trial update describes the development of a predictive model to forecast immunotherapy response in non-resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Pancreatic Cancer Non-resectable | Status: ACTIVE_NOT_RECRUITING